When did MBX Biosciences, Inc. report Q4 2024 earnings?

MBX Biosciences, Inc. (MBX) reported Q4 2024 earnings on March 17, 2025 before market open.

What were MBX Biosciences, Inc.'s Q4 2024 revenue and EPS?

MBX Biosciences, Inc. reported diluted EPS of $-0.47 for Q4 2024.

Did MBX Biosciences, Inc. beat estimates in Q4 2024?

EPS beat the consensus estimate of $-0.59 by $0.12.

Where can I find MBX Biosciences, Inc.'s Q4 2024 SEC filings?

You can read the 10-K periodic report (0000950170-25-039838) directly on SEC EDGAR. The filing index links above go to sec.gov.

MBX Biosciences, Inc. MBX Q4 2024 Annual earnings

Reported March 17, 2025 · Before market open

Diluted EPS-$0.47Beat by $0.12

EPS estimate-$0.59

Next report

Aug 6, 2026 (in a month)

EPS estimate-$0.68

Financials

Q4 2024

Income statement

See full

Operating income-$18.6M-86.3%

Net income-$15.6M-76.3%

Balance sheet

See full

Cash & equivalents$49.4M+61.7%

Total debt$171.0K-47.2%

Total equity$257.4M+455%

Total assets$268.5M+219%

Cash flow

See full

Operating cash flow-$16.0M-43.9%

CapEx$92.0K+67.3%

Free cash flow-$16.1M-44.0%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$615.88M—

Enterprise value$566.7M—

Returns & leverage

See full

Debt / equity0×—

Current ratio24.2×+2.9×

Versus estimates

Diluted EPS

Q1 2026-$0.51Beat by $0.11 Q4 2025-$0.49Beat by $0.15 Q3 2025-$0.63Beat by $0.10 Q2 2025-$0.58Beat by $0.19 Q1 2025-$0.71Beat by $0.10

Q4 2024-$0.47Beat by $0.12

Ask the moment MBX Biosciences, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did MBX Biosciences, Inc. report Q4 2024 earnings?: MBX Biosciences, Inc. (MBX) reported Q4 2024 earnings on March 17, 2025 before market open.
What were MBX Biosciences, Inc.'s Q4 2024 revenue and EPS?: MBX Biosciences, Inc. reported diluted EPS of $-0.47 for Q4 2024.
Did MBX Biosciences, Inc. beat estimates in Q4 2024?: EPS beat the consensus estimate of $-0.59 by $0.12.
Where can I find MBX Biosciences, Inc.'s Q4 2024 SEC filings?: You can read the 10-K periodic report (0000950170-25-039838) directly on SEC EDGAR. The filing index links above go to sec.gov.